Результати пошуку - Chrones, Lambros
- Показ 1 - 5 результатів із 5
-
1
A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor за авторством Tsai, Max, Chrones, Lambros, Xie, Jinhui, Gevorkyan, Hakop, Macek, Thomas A.
Опубліковано 2016Текст -
2
Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study за авторством Jacobsen, Paula L., Harper, Linda, Chrones, Lambros, Chan, Serena, Mahableshwarkar, Atul R.
Опубліковано 2015Текст -
3
Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis за авторством Kangethe, Anne, Lawrence, Debra F., Touya, Maëlys, Chrones, Lambros, Polson, Michael, Evangelatos, Themmi
Опубліковано 2021Текст -
4
Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data за авторством Touya, Maëlys, Lawrence, Debra F., Kangethe, Anne, Chrones, Lambros, Evangelatos, Themmi, Polson, Michael
Опубліковано 2022Текст -
5
The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies за авторством Baldwin, David S, Chrones, Lambros, Florea, Ioana, Nielsen, Rebecca, Nomikos, George G, Palo, William, Reines, Elin
Опубліковано 2016Текст